Merit Medical Systems, Inc. MMSI
88.04 USD +3.88 (+4.61%)
Nov 4, 2026, 10:15 AM EST
86.04 Day range 88.45
59.74 52-week range 94.85
- YTD
- -0.11%
- 1 year
- -0.49%
Analyst view
Consensus: buy
Buy
Price target (mean) 107.00 +21.5% upside
Now 88.04
- Target (low)
- 90.00
- Target (mean)
- 107.00
- Target (high)
- 123.00
Ratings (0m) 12 9 buy · 3 hold · 0 sell
- Strong buy5
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.11 | 1.09 – 1.13 | 1.04 | +6.3% | 422.77M | +7.3% | 11 |
| Next quarter | 1.02 | 0.99 – 1.05 | 0.94 | +9.0% | 408.89M | +7.1% | 9 |
| Current year | 4.35 | 4.34 – 4.36 | 3.83 | +13.6% | 1.64B | +8.1% | 11 |
| Next year | 4.67 | 4.51 – 4.82 | 4.35 | +7.3% | 1.74B | +6.2% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Needham | Maintained | Buy | Buy |
| Oct 30, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 27, 2026 | Freedom Capital Markets | Initiated | — | Hold |
| Sep 29, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 13, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Aug 11, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2026 | Needham | Maintained | Buy | Buy |
| Jul 31, 2026 | BTIG | Maintained | Buy | Buy |
| May 1, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 1, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 1, 2026 | Needham | Maintained | Buy | Buy |
| Apr 20, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Apr 17, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 1, 2026 | Needham | Reiterated | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Feb 25, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Feb 18, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 6, 2026 | BTIG | Initiated | — | Buy |
| Jan 9, 2026 | Needham | Reiterated | Buy | Buy |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
